Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 4 announcements

Share price: ₹2.60
Market cap: ₹19.70 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -12.2×Sector 57.8×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

7 Aug 2026 11:43 IST BSE

Financial Results

Transgene Biotek Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens

Transgene Biotek Ltd reported revenue from operations of ₹0.1 Cr and a net loss of ₹0.4 Cr for Q1 FY27.

Key figure: Net loss ₹0.4 Cr

Open full results → Read the filing ↗